MiNK Therapeutics, Inc.
INKT
$8.41
-$0.34-3.89%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 51.98% | 44.36% | 34.23% | 20.52% | 19.77% |
| Total Depreciation and Amortization | 5.23% | 13.81% | 25.69% | 51.67% | 68.20% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -84.58% | -69.84% | 3.01% | 779.71% | 1,422.71% |
| Change in Net Operating Assets | -84.13% | -58.99% | -59.60% | -50.17% | -66.95% |
| Cash from Operations | 39.38% | 36.68% | 34.93% | 26.78% | 16.45% |
| Capital Expenditure | -- | 100.00% | 90.34% | 77.23% | 70.60% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 100.00% | 90.34% | 77.23% | 70.60% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 8,155.32% | 8,143.63% | 8,440.68% | -31.25% | 4,306.25% |
| Repurchase of Common Stock | 100.00% | 100.00% | 100.00% | 81.81% | -203.82% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,757.82% | 2,758.48% | 2,741.32% | 1,105.54% | -161.63% |
| Foreign Exchange rate Adjustments | -116.67% | -554.24% | -65.03% | -101.89% | -229.90% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 107.44% | 99.60% | 93.19% | 54.16% | 15.50% |
